AcoArt Ⅰ / SFA China

NCT01850056 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-07-12

No results posted yet for this study

Summary

The purpose of this study is to determine whether DEB is more effective than common PTA balloon in long-term vessel patency and inhibiting restenosis.

Conditions

Interventions

DEVICE

drug eluting balloon catheter (trade name: Orchid)

DEVICE

common percutaneous transluminal angioplasty balloon catheter (trade name: Admiral)

Sponsors & Collaborators

  • Acotec Scientific Co., Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2016-08-31
Completion
2016-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01850056 on ClinicalTrials.gov